Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2026-01-17 @ 2:26 AM
Study NCT ID:
NCT02872259
Status:
COMPLETED
Last Update Posted:
2025-01-14
First Post:
2016-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma
Sponsor:
Organization: